Home » Topics » BioWorld Science

BioWorld Science
RSS

UCB describes new antimalarial compounds

March 17, 2021

AB-205 eliminates oral and gastrointestinal SRRT in adults undergoing HDT-AHCT

March 17, 2021

FDA clears IND for phase II study of CYTO-205 as treatment of mild COVID-19

March 17, 2021

Galmed initiates dosing in first-in-human phase I trial of Amilo-5MER

March 17, 2021

Arbutus receives regulatory approval for phase Ia/Ib trial of AB-836 in chronic HBV infection

March 17, 2021

First patient dosed in phase I study of emricasan in mild symptomatic COVID-19

March 17, 2021

First patients dosed in global phase I study of ADG-126

March 17, 2021

Pliant completes phase I study of PLN-1474 and transfers the candidate to Novartis

March 17, 2021

Multimorbid diseases cluster in predictable ways: study

March 17, 2021

Moderna initiates phase I study of its next-generation COVID-19 vaccine, mRNA-1283

March 17, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...